Avibactam (sodium)


CAS No. : 1192491-61-4

(Synonyms: NXL-104)

1192491-61-4
Price and Availability of CAS No. : 1192491-61-4
Size Price Stock
5mg $72 In-stock
10mg $96 In-stock
50mg $156 In-stock
100mg $228 In-stock
200mg $312 In-stock
500 mg Get quote
1 g Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-14879A
M.Wt: 287.23
Formula: C7H10N3NaO6S
Purity: >98 %
Solubility: H2O : 50 mg/mL (ultrasonic);DMSO : ≥ 30 mg/mL
Introduction of 1192491-61-4 :

Avibactam sodium (NXL-104) is a covalent and reversible non-β-lactam β-lactamase inhibitor which inhibits β-lactamase TEM-1 and CTX-M-15 with IC50s of 8 nM and 5 nM, respectively[1]. IC50 & Target: IC50: 5 nM (CTX-M-15), 8 nM (TEM-1)[1] In Vitro: Avibactam is a molecule with little antibacterial activity, that inhibits class A and C β-lactamases, but not metallo types and Acinetobacter OXA carbapenemases[2].
Ceftazidime (HY-B0593)-Avibactam (0-256 mg/L) inhibits 16 blaKPC-2 positive and 1 of blaOXA-232 positive Klebsiella pneumonia growth with MIC50 and MIC90 for both 8?mg/L[4]. In Vivo: Ceftazidime-Avibactam (0.375?mg/g; s.c.; q8h for 10 days) has a significant effect on the bacteria and led to a certain therapeutic efficacy in K. pneumoniae strain Y8 infected mouse model[3].
Avibactam (64 mg/kg; s.c.; once) shows mean estimated half-life in plasma in the terminal phase of 0.24 h in Pseudomonas aeruginosa infected neutropenic mice with lung infection[3].

Your information is safe with us.